What is B. Riley’s Estimate for Core Scientific Q1 Earnings?

Core Scientific, Inc. (NASDAQ:CORZ) – Stock analysts at B. Riley decreased their Q1 2025 earnings per share estimates for shares of Core Scientific in a research note issued on Monday, April 28th. B. Riley analyst N. Giles now forecasts that the company will earn ($0.16) per share for the quarter, down from their prior estimate of ($0.10). The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. B. Riley also issued estimates for Core Scientific’s Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.07) EPS, Q4 2025 earnings at ($0.04) EPS, FY2025 earnings at ($0.37) EPS and FY2026 earnings at ($0.04) EPS.

Several other research firms also recently commented on CORZ. Craig Hallum assumed coverage on shares of Core Scientific in a research note on Tuesday, January 21st. They issued a “buy” rating and a $24.00 price target on the stock. Compass Point cut their price objective on shares of Core Scientific from $26.00 to $20.00 and set a “buy” rating for the company in a report on Tuesday, February 25th. Canaccord Genuity Group reissued a “buy” rating and issued a $17.00 price objective on shares of Core Scientific in a report on Wednesday, March 12th. Cantor Fitzgerald cut their price objective on shares of Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Finally, Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a report on Monday, January 27th. They issued an “outperform” rating and a $22.00 price objective for the company. Fifteen research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $19.07.

Core Scientific Trading Up 5.6 %

CORZ opened at $8.55 on Thursday. The stock has a market cap of $2.52 billion, a PE ratio of -1.58 and a beta of 6.80. The stock’s fifty day simple moving average is $8.07 and its 200 day simple moving average is $12.25. Core Scientific has a 1-year low of $3.05 and a 1-year high of $18.63.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The business had revenue of $94.93 million during the quarter, compared to the consensus estimate of $97.07 million.

Hedge Funds Weigh In On Core Scientific

A number of institutional investors have recently added to or reduced their stakes in CORZ. Vanguard Group Inc. increased its position in Core Scientific by 54.3% in the 4th quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock valued at $272,270,000 after acquiring an additional 6,819,406 shares during the period. Beryl Capital Management LLC increased its position in Core Scientific by 24.3% in the 4th quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company’s stock valued at $255,423,000 after acquiring an additional 3,548,396 shares during the period. Driehaus Capital Management LLC increased its position in Core Scientific by 112.1% in the 4th quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company’s stock valued at $144,212,000 after acquiring an additional 5,424,901 shares during the period. ORG Wealth Partners LLC increased its position in Core Scientific by 0.3% in the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock valued at $126,262,000 after acquiring an additional 26,649 shares during the period. Finally, FMR LLC increased its position in Core Scientific by 2,937.7% in the 4th quarter. FMR LLC now owns 7,436,229 shares of the company’s stock valued at $104,479,000 after acquiring an additional 7,191,428 shares during the period.

Insider Activity

In related news, Director Todd A. Becker sold 134,250 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the completion of the transaction, the director now directly owns 195,687 shares in the company, valued at $2,103,635.25. This represents a 40.69 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jordan Levy acquired 62,500 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were bought at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the transaction, the director now owns 306,887 shares in the company, valued at $2,458,164.87. This represents a 25.57 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.40% of the company’s stock.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.